March 2, 2022
With recent expansion into veterinary field, Innocan Pharma is primed for major growth
Innocan Pharma (CSE:INNO) As investors, we always need to be prudent with our research into potential investments. There are tens of thousands of stocks across dozens of exchanges, all with their own individual stories. Everyone wants to be the first to invest in a developing industry, but few manage to get the timing correctly. If it were that easy, we …
